[White Paper] Part 2: Facility and Engineering Control Design Under USP <800>
Design considerations for creating a Pharmacy USP 800 compliant Hazardous Drug (HD) compounding operation.
[Webinar] Engineering Control Options Under USP <800>
Watch and listen to Bryan Prince, owner of Lab-Red Pharmacy Consultants, discuss Engineering Control Options Under USP 800.
[Webinar] Budgeting for USP 800
Budget considerations for cleanroom construction. Weigh the options between new construction versus remodeling, and other dilemmas that hospital pharmacies may face preparing for USP 800 compliance.
[Webinar] USP Compliance: USP 795 Facility Requirements
Bryan Prince reviews the timeline for USP 795 compliance, QC processes for nonsterile compounding, staff training steps, and more.
[White Paper] How to Perform a Hazardous Drug Risk Assessment in the Compounding Pharmacy
How to Perform a Hazardous Drug Risk Assessment in the Compounding Pharmacy.
[White Paper] Workflow Strategies to Minimize Exposure to Hazardous Drugs in the Compounding Pharmacy
Handling hazardous drugs in the compounding pharmacy, per USP chapter <800> guidelines, involves strategic workflow strategies with the goal of minimizing personnel and environmental exposure.
[White Paper] USP 800 Gap Analysis, A Business Perspective
USP 800 is going to financially impact your pharmacy’s future business model so this white paper focuses on five important details that define the "why" for considering a capital investment.
[White Paper] Can a Class I and Class II BSC be in the same Sterile Hazardous Drug (HD) Room?
USP 800 does not directly address the pre-sterilization process of a sterile preparation creating the question can a class I and a Class II biosafety cabinet be used in the same sterile HD room?
[White Paper] Part 1: Facility and Engineering Control Design Under USP <800>
The focus of this article is to discuss the details for consideration of a good working design of a USP 800 compliant compounding lab.